Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Neoplasms
Clinical trial register · United States · industry-sponsored

Neoplasms Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9140 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 20 Oct 2026, 03:16 UTC
9140
Studies in scope
industry-sponsored, all four open statuses
4969
Recruiting now
open to new participants
2198
Lead sponsors
across recruiting studies
Top states
California 23 Florida 15 Texas 13 Colorado 12 Georgia 11
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
GlaxoSmithKline9 Janssen Research & Development, LLC4 Tesaro, Inc.3 Eli Lilly and Company3 USWM CT, LLC2
State
California23 Florida15 Texas13 Colorado12 Georgia11
All 35 states
Target enrolment
to

Neoplasms trials in the USA

33 of 9140 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 1
66
Florida, Minnesota, New York, Texas
2026-05-18
Recruiting
GlaxoSmithKline
Phase 1
97
Pennsylvania, Texas
2026-03-23
Recruiting
Corcept Therapeutics
Phase 1/2
50
California, Illinois, Michigan, Texas, Utah
2026-01-16
Recruiting
Eli Lilly and Company
Phase 1
41
Connecticut, Massachusetts, Michigan, New York
2025-12-22
Recruiting
GlaxoSmithKline
Phase 1
83
Florida, New York, Pennsylvania, Tennessee, Texas
2025-12-03
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
California, Colorado, Florida, Georgia, Illinois, Indiana, Mississippi, New York
2025-11-28
Recruiting
GlaxoSmithKline
Phase 1/2
47
Colorado, Michigan, Ohio, Tennessee
2025-10-20
Recruiting
Hoffmann-La Roche
Phase 1
405
California, Colorado, Connecticut, Florida, Texas
2025-04-30
Recruiting
GlaxoSmithKline
Phase 1
845
California, Colorado, Connecticut, Indiana, Massachusetts, Michigan, New Jersey, South Carolina
2024-09-30
Recruiting
GlaxoSmithKline
Phase 1
675
Alabama, California, Florida, Kansas, Massachusetts, Michigan, Minnesota, New York
2024-07-02
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 1
126
New York, Pennsylvania, Texas
2024-04-10
Recruiting
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
NCT06271252Neoplasms, Plasma Cell, Neoplasms by Histologic Type, Neoplasms, Hemostatic Disorders
DrugOriCAR-017
OriCell Therapeutics Co., Ltd.
Phase 1
81
Georgia
2024-04-03
Recruiting
Janssen Research & Development, LLC
Phase 1
300
California, Colorado, Florida, Georgia, Michigan, New Jersey, New York, North Carolina
2023-12-20
Recruiting
A Study of JNJ-87890387 for Advanced Solid Tumors
NCT06178614Neoplasms, Advanced Solid Tumors
Janssen Research & Development, LLC
Phase 1
200
Michigan, Tennessee
2023-12-14
Active, closed
GlaxoSmithKline
Phase 1/2
42
California, Missouri, Texas, Virginia
2023-10-24
Recruiting
Stemline Therapeutics, Inc.
Phase 1/2
73
California, Illinois, Massachusetts, Michigan, Ohio, Oregon, Tennessee, Texas
2022-08-31
Active, closed
GlaxoSmithKline
Phase 1
152
California, North Carolina, Oklahoma, Pennsylvania, Texas, Utah
2022-03-22
Active, closed
Boehringer Ingelheim
Phase 1
151
Arizona, California, North Carolina, South Dakota, Texas
2021-10-18
Active, closed
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
NCT04673942Solid Tumor, Adult, Cancer, Neoplasms, Sarcoma
EpicentRx, Inc.
Phase 2
140
California, Ohio, Texas
2021-03-29
Active, closed
Pfizer
Phase 3
841
Arizona, California, Florida, Illinois, Louisiana, Minnesota, Missouri, Nebraska
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 1
158
California, Indiana, New York, Oregon, Tennessee
2020-11-10
Active, closed
GlaxoSmithKline
Phase 1
107
California, Massachusetts, Texas
2020-06-25
Recruiting
Eli Lilly and Company
Phase 2
105
Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois
2020-01-22
Recruiting
Abbisko Therapeutics Co, Ltd
Phase 1
276
California, Colorado, Georgia, Texas
2020-01-20
Active, closed
USWM CT, LLC
Phase 2
103
California, Colorado, Florida, Illinois, Iowa, Massachusetts, Michigan, Minnesota
2019-12-31
Active, closed
Tesaro, Inc.
Phase 3
785
Arizona, California, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky
2019-07-18
Active, closed
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
NCT04008797Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms
DrugsE7386·Doxorubicin·Lenvatinib·Paclitaxel
Eisai Inc.
Phase 1/2
301
Arkansas, California, Colorado, Florida, Louisiana, Mississippi, Missouri, New York
2019-07-11
Recruiting
Celgene
Phase 2/3
1,541
Alabama, Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia
2018-07-19
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Arizona, California, Colorado, Florida, Georgia, Maryland, Massachusetts, Minnesota
2018-05-03
By invitation
USWM CT, LLC
Phase 1
250
Georgia, Maryland, Michigan, Missouri, New York, North Carolina, Oregon, Pennsylvania
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 1/2
234
Missouri, Pennsylvania
2016-11-21
Active, closed
Tesaro, Inc.
Phase 1
463
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2016-07-08
Active, closed
Tesaro, Inc.
Phase 1
729
Alabama, Arizona, Arkansas, California, District of Columbia, Florida, Georgia, Illinois
2016-03-07
Rows per page Showing 1–33 of 33
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-usa/condition/neoplasms

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,140 studies in total at the last sync on 20 Oct 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 33 of those studies listing the condition Neoplasms.

How many Neoplasms trials are recruiting in the US?

18 of the 33 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 14 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Neoplasms), 33 studies
PhaseStudiesRecruitingShare
Phase 1191257.6%
Phase 1/26318.2%
Phase 25215.2%
Phase 3206.1%
Phase 2/3113%

Most active sponsors

Lead sponsors with the most studies (Neoplasms)
Lead sponsorStudiesRecruiting
GlaxoSmithKline95
Janssen Research & Development, LLC42
Eli Lilly and Company33
Tesaro, Inc.30
Johnson & Johnson Enterprise Innovation Inc.22
USWM CT, LLC20
Abbisko Therapeutics Co, Ltd11
Boehringer Ingelheim10
Celgene11
Corcept Therapeutics11

Top states

Top states (Neoplasms), by number of studies with a site there
StateStudies
California23
Florida15
Texas13
Colorado12
Georgia11
Michigan10
New York10
Illinois9
Arizona8
Massachusetts7
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.